For laboratory research only
Compare Bremelanotide research suppliers
Listings now default to lowest tracked price per mg. The highlighted price badge is a catalog-price signal only, not a quality, safety, or documentation ranking.
The document count covers six basic checks. “Not found” means we could not confirm it from the public records we reviewed—not that the testing never happened.
Affiliate disclosure: Some links may earn PDD a commission. Affiliate status does not change what we report or how suppliers are ordered.
Elite Research Labs
6 of 6 fields documentedChecked 12 days agoPT-141 (10 mg)
Documented alias catalog match · Affiliate relationship · Price badge is not an overall recommendation
Listed price
$33.99
$3.40 per mg
In stock
Eppix Labs
5 of 6 fields documentedReview recommendedPT-141 (10 mg)
Documented alias catalog match · No active affiliate relationship
Listed price
$34.99
$3.50 per mg
In stock
True Peptides
1 of 6 fields documentedPossibly outdatedPT-141 (10 mg)
Documented alias catalog match · Affiliate relationship
Listed price
$43.00
$4.30 per mg
In stock
PS Peptides
5 of 6 fields documentedPossibly outdatedPT-141 (10 mg)
Documented alias catalog match · Affiliate relationship
Listed price
$44.99
$4.50 per mg
Est. with PDD10: $40.49
$4.05/mg
In stock
Ascension Peptides
2 of 6 fields documentedPossibly outdatedPT-141 (10 mg)
Documented alias catalog match · Affiliate relationship
Listed price
$49.00
$4.90 per mg
In stock
How Bremelanotide is used in research
Bremelanotide is related to the melanocortin peptide family and has been investigated for central melanocortin-receptor signaling and behavioral-response endpoints.
Its regulatory history makes product-level distinctions essential: FDA approval applies to a specific prescription product, formulation, labeling, and indicated population—not to every research material sold under the same molecule name.
Evidence map
Research stage matters. Findings from one model should not be silently promoted to another.
Laboratory
Receptor studies characterize melanocortin subtype activity.
Animal
Preclinical work evaluated neurobehavioral and physiological responses.
Human
Clinical trials supported one specific FDA-approved prescription product.
What the evidence does not establish
Evidence for an approved product cannot be transferred to an unapproved vial, formulation, supplier, route, or use.
Study findings also do not authenticate a supplier’s material. Biological plausibility, a familiar name, or a published paper cannot substitute for lot-specific identity and quality evidence.
Analytical and documentation checks
The test plan should match the exact molecule, modification, and research question.
- Confirm cyclic structure and expected molecular identity.
- Distinguish active ingredient identity from finished-product equivalence.
- Do not infer approved-product quality from a research-material COA.
At minimum, connect the product name, sequence, sample identifier, lot, report, method, expected result, and observed result. Record untested attributes as “not reported,” not as assumed passes.
Build the documentation record
Regulatory status
Vyleesi is an FDA-approved prescription product containing bremelanotide for a defined indication. Other bremelanotide materials do not inherit that approval.
Regulatory status can change and attaches to specific products and jurisdictions. Verify current official records before publishing, procuring, or relying on a status claim.
Primary sources and official records
Use these records as starting points, then assess the exact model, test article, methods, and date:
Peptide Due Diligence Research Brief
Follow the evidence, not the headline.
Receive new evidence maps, documentation guides, and material corrections as the directory expands.
By subscribing, you agree to receive PDD research emails. Unsubscribe at any time.
Already subscribed? Get your free checklist.